Factors Affecting Management Delay in Breast Cancer among the Patients Referred to Omid and Alzahra Hospitals in Isfahan, Iran, during 2016-2017

Document Type : Original Article (s)

Authors

1 Assistant Professor, Department of Hematology and Oncology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

2 Student of Medicine, Student Research Committee, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

3 Assistant Professor, Department of Pathology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

Abstract

Background: Most patients with breast cancer refer to their doctor when their disease is in the advanced stage. Considering the lack of study on the causes associated with delay in management of patients in Isfahan, Iran, this study aimed to examine factors related to the delay in the care of patients with breast cancer.Methods: In this cross-sectional study, 70 patients with breast cancer who referred to Omid and Alzahra hospitals in Isfahan were interviewed. Then, based on the researcher-made questionnaire which included demographic information, patient delay factors, delay factors of health and treatment system, referring and treatment times, and information on the condition of cancer, the factors associated with the delay in patient care were assessed.Findings: The mean time was 4.67 ± 1.57 months from symptoms appearance to the referral to physician, and 7.21 ± 2.89 months from the presence of symptoms to the diagnosis. The mean score of the patient delay was also relatively high.Conclusion: Due to the fact that the most prevalent reason for management delay in patients with breast cancer is patient delay in going to a physician to perform diagnostic procedures, appropriate control and symptom training

Keywords

References

  1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015; 136(5): E359-E386.
  2. Fitzmaurice C, Dicker D, Pain A, Hamavid H, Moradi-Lakeh M, MacIntyre MF, et al. The Global Burden of Cancer 2013. JAMA Oncol 2015; 1(4): 505-27.
  3. Sadjadi A, Nouraie M, Ghorbani A, Alimohammadian M, Malekzadeh R. Epidemiology of breast cancer in the Islamic Republic of Iran: first results from a population-based cancer registry. East Mediterr Health J 2009; 15(6): 1426-31.
  4. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61(2): 69-90.
  5. Elsawaf Z, Sinn HP, Rom J, Bermejo JL, Schneeweiss A, Aulmann S. Biological subtypes of triple-negative breast cancer are associated with distinct morphological changes and clinical behaviour. Breast 2013; 22(5): 986-92.
  6. Caplan L. Delay in breast cancer: implications for stage at diagnosis and survival. Front Public Health 2014; 2: 87.
  7. Richards MA, Westcombe AM, Love SB, Littlejohns P, Ramirez AJ. Influence of delay on survival in patients with breast cancer: A systematic review. Lancet 1999; 353(9159): 1119-26.
  8. Burgess C, Hunter MS, Ramirez AJ. A qualitative study of delay among women reporting symptoms of breast cancer. Br J Gen Pract 2001; 51(473): 967-71.
  9. Jassem J, Bacanu F, Eglitis J, Mardiak J, Pienkowski T, Kahan Z, et al. Patient-related factors influencing time between first signs of breast cancer (BC) and appointment for medical visit (AMV): An international survey. Alexandria, VA: American Society of Clinical Oncology; 2012.
  10. Hansen RP, Vedsted P, Sokolowski I, Sondergaard J, Olesen F. Time intervals from first symptom to treatment of cancer: a cohort study of 2,212 newly diagnosed cancer patients. BMC Health Serv Res 2011; 11: 284.
  11. Veisani Y, Delpisheh A, Sayehmiri K, Rahimi E. Survival rate estimation and its associated factors in patients with stomach cancer in Tohid Hospital in Sanandaj. Sci J Kurdistan Univ Med Sci 2013; 18(2): 1-8. [In Persian].
  12. Smith LK, Pope C, Botha JL. Patients' help-seeking experiences and delay in cancer presentation: a qualitative synthesis. Lancet 2005; 366(9488): 825-31.
  13. Unger-Saldana K, Miranda A, Zarco-Espinosa G, Mainero-Ratchelous F, Bargallo-Rocha E, Miguel Lazaro-Leon J. Health system delay and its effect on clinical stage of breast cancer: Multicenter study. Cancer 2015; 121(13): 2198-206.
  14. Allgar VL, Neal RD. Delays in the diagnosis of six cancers: analysis of data from the National Survey of NHS Patients: Cancer. Br J Cancer 2005; 92(11): 1959-70.
  15. Jassem J, Ozmen V, Bacanu F. Factors influencing time to seeking medical advice and start of treatment in breast cancer-an international survey. Proceedings of the 35th Annual CTRC-AACR San Antonio Breast Cancer Symposium; 2012 Dec 4-8; San Antonio, TX, USA.
  16. Montella M, Crispo A, D'Aiuto G, de Marco M, de Bellis G, Fabbrocini G, et al. Determinant factors for diagnostic delay in operable breast cancer patients. Eur J Cancer Prev 2001; 10(1): 53-9.
  17. Ozmen V, Boylu S, Ok E, Canturk NZ, Celik V, Kapkac M, et al. Factors affecting breast cancer treatment delay in Turkey: A study from Turkish Federation of Breast Diseases Societies. Eur J Public Health 2015; 25(1): 9-14.
  18. Arndt V, Sturmer T, Stegmaier C, Ziegler H, Becker A, Brenner H. Provider delay among patients with breast cancer in Germany: A population-based study. J Clin Oncol 2003; 21(8): 1440-6.
Journal of Isfahan Medical School
Volume 36, Issue 489 - Serial Number 489
July and August 2018
Pages 853-858

Files

History

  • Receive Date: 21 June 2018
  • Revise Date: 01 November 2024
  • Accept Date: 06 April 2022

Share

How to cite

Statistics